Breast Carcinoma Clinical Trials in St Louis, Missouri

3 studies are recruiting for breast carcinoma in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Vanguard Study: Testing a New Way to Screen for Cancer

    The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a need to understand h…

    Stage
    Not phased
    Ages
    45 to 75
    Site
    Washington University School of Medicine, St Louis, Missouri
    Locations
    44 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT06995898 on ClinicalTrials.gov

  2. Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

    This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well established risk factor for breast cancer. Tamoxifen is a selective estrogen receptor modulator. It works …

    Stage
    Phase 2
    Ages
    18 to 55
    Site
    Washington University School of Medicine, St Louis, Missouri
    Locations
    11 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT06184750 on ClinicalTrials.gov

  3. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mercy Hospital South, St Louis, Missouri
    Locations
    467 in total
    Run by
    Wake Forest University Health Sciences

    See if you can join NCT06418204 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.